Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Creative Biolabs provides a wide range of high-quality anti-FCRL5 recombinant antibodies engineered for precision in immunological research applications. Our advanced techniques ensure exceptional specificity and affinity, making these antibodies ideal for diverse assays. Rigorous validation guarantees optimal performance, supporting the success and reliability of your projects.
FCRL5, a key member of the immunoglobulin superfamily, plays a critical role in regulating immune responses and is implicated in various diseases. Its unique expression profile in myeloma, with nearly 100% of tumor cells expressing it compared to significantly lower levels in normal B cells, makes it a promising target for developing novel therapies against this malignancy. Additionally, FCRL5's involvement in B-cell development and its association with lymphoid malignancies further solidify its potential as a valuable diagnostic and therapeutic marker in hematological cancers.
Fc receptor-like 5; Fc receptor like 5; Fc Receptor-Like Protein 5; Fc Receptor Homolog 5; FcR-Like Protein 5; Immune Receptor Translocation-Associated Protein 2; FcRH5; IRTA2; CD307; BXMAS1; CD307; CD307e; PRO820.
CD markers, Disease related genes
Membrane, Secreted (different isoforms)
Group enriched (Plasma cells, B-cells, Early spermatids)
Group enriched (naive B-cell, memory B-cell)
Group enriched (U-266/70, U-698)
Receptor
Creative Biolabs offers a comprehensive selection of anti-FCRL5 recombinant antibodies designed for precise targeting and neutralization of FCRL5. These antibodies, available in various derivations, exhibit exceptional specificity and affinity, making them ideal for various experimental applications including Western Blot, immunoprecipitation, ELISA, immunohistochemistry, and immunofluorescence. Whether conducting research or developing therapeutic strategies, Creative Biolabs' anti-FCRL5 antibodies are indispensable tools for advancing scientific understanding in immunology, oncology, and related fields.
Table 1. Featured anti-FCRL5 recombinant antibody products at Creative Biolabs.
Cat. No. | Product Name | Target Species | Host Species | Applications |
HPAB-AP650-YC | Mouse Anti-FCRL5 Recombinant Antibody (HPAB-AP650-YC) | Human | Mouse IgG | FC, FuncS |
MOB-056CQ | Mouse Anti-FCRL5 Recombinant Antibody (MOB-056CQ) | Human | Mouse IgG1, κ | ELISA, FC, FuncS |
MOB-057CQ | Mouse Anti-FCRL5 Recombinant Antibody (clone 13G9) | Human | Mouse IgG1, κ | ELISA, FC, FuncS |
TAB-0591CL | Mouse Anti-FCRL5 Recombinant Antibody (TAB-0591CL) | Human | Mouse IgG1 | FC, IF, WB, ELISA |
TAB-0590CL | Mouse Anti-FCRL5 Recombinant Antibody (TAB-0590CL) | Human | Mouse IgG2a | FC, WB, ELISA |
Creative Biolabs is committed to providing superior anti-FCRL5 recombinant antibodies tailored for research purposes. Our state-of-the-art facilities and rigorous quality assurance processes ensure exceptional specificity and binding affinity. Backed by a team of dedicated biotechnology experts, we continuously strive to improve our processes and deliver cutting-edge solutions for your scientific endeavors.
Fig.1 SDS-PAGE analysis of anti-FCRL5 antibody
(Cat# MOB-056CQ, Creative Biolabs).
Fig.2 HPLC analysis of anti-FCRL5 antibody
(Cat# MOB-056CQ, Creative Biolabs).
Fig.3 ELISA analysis of anti-FCRL5 antibody
(Cat# MOB-056CQ, Creative Biolabs).
Fig.4 WB analysis of anti-FCRL5 antibody
(Cat# MOB-056CQ, Creative Biolabs).
Fig.5 DB analysis of anti-FCRL5 antibody
(Cat# MOB-056CQ, Creative Biolabs).
Fig.6 ELISA analysis of anti-FCRL5 antibody
(Cat# TAB-0591CL, Creative Biolabs).
Creative Biolabs employs a cutting-edge recombinant antibody production platform for anti-FCRL5 recombinant antibody production. Our advanced genetic engineering techniques enable the flexible production of high-quality antibodies, ensuring a reliable supply to meet the demands of research and therapeutic endeavors.
Featured Anti-FCRL5 Recombinant Antibody Production Platforms
Fig.7 Milligram-scale anti-FCRL5 recombinant antibody production.
Fig.8 Gram-scale anti-FCRL5 recombinant antibody production.
Creative Biolabs provides an extensive selection of premium anti-FCRL5 recombinant antibodies, available in multiple formats to cater to the varied requirements of the research community.
Fig.9 Full-length anti-FCRL5 recombinant antibody production and modalities.
Table 2. Public drug targeting FCRL5.
Company | Research Phase | Classification | Condition |
Chugai Pharmaceutical Genentech Roche (Originator) |
Phase I/II |
Bispecific Antibodies Cancer Immunotherapy Monoclonal Antibodies |
Multiple myeloma |
First Affiliated Hospital Soochow Univ (Originator) Soochow University (Originator) |
Preclinical |
Cancer Immunotherapy Chimeric Antigen Receptor-Modified T Cells (CAR T Cells) (Second-Generation CAR) |
Multiple myeloma |
Genentech (Originator) Roche (Originator) |
Preclinical |
Bispecific Antibodies Cancer Immunotherapy Humanized Monoclonal Antibodies |
Multiple myeloma |
Celgene (Originator) | Biological Testing |
Antibody-Derived Binding Proteins Bispecific Antibody Fusions Cancer Immunotherapy Fusion Proteins Polypeptides, from 41 AA |
Lymphoma, B-cell |
Immuneel (Originator) | Biological Testing |
Cancer Immunotherapy Chimeric Antigen Receptor-Modified T Cells (CAR T Cells) (Second-Generation CAR) |
Cancer |
Shandong Bang'entai Biomedical Technology Group (Originator) | Biological Testing |
Cancer Immunotherapy Chimeric Antigen Receptor-Modified T Cells (CAR T Cells) (Second-Generation CAR) |
Multiple myeloma |
Nanjing Zilong Biotechnology (Originator) | Biological Testing |
Cancer Immunotherapy Chimeric Antigen Receptor-Modified T Cells (CAR T Cells) (Second-Generation CAR) |
Cancer |
Washington University (Originator) | Biological Testing |
Cancer Immunotherapy Chimeric Antigen Receptor-Modified T Cells (CAR T Cells) |
Multiple myeloma |
Jinan Taihe Pharmaceutical Technology (Originator) | Biological Testing |
Cancer Immunotherapy Chimeric Antigen Receptor-Modified T Cells (CAR T Cells) (Second-Generation CAR) |
Cancer |
Soochow University (Originator) | Biological Testing |
Cancer Immunotherapy Chimeric Antigen Receptor-Modified T Cells (CAR T Cells) (Second-Generation CAR) |
Multiple myeloma |
(Disclaimer: The information in this table is just for knowledge sharing and not for marketing or sales purposes.)
Please feel free to get in touch with us if you are seeking a premium anti-FCRL5 recombinant product.